TRAIL acts synergistically with iron oxide nanocluster-mediated magneto- and photothermia

Targeting TRAIL (Tumor necrosis factor (TNF)-Related Apoptosis-Inducing Ligand) receptors for cancer therapy remains challenging due to tumor cell resistance and poor preparations of TRAIL or its derivatives. Herein, to optimize its therapeutic use, TRAIL was grafted onto iron oxide nanoclusters (NC...

Descripción completa

Detalles Bibliográficos
Autores principales: Belkahla, Hanene, Mazarío, Eva, Sangnier, Anouchka Plan, Lomas, John S., Gharbi, Tijani, Ammar, Souad, Micheau, Olivier, Wilhelm, Claire, Hémadi, Miryana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735372/
https://www.ncbi.nlm.nih.gov/pubmed/31534529
http://dx.doi.org/10.7150/thno.36320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735372/
https://www.ncbi.nlm.nih.gov/pubmed/31534529
http://dx.doi.org/10.7150/thno.36320

Ejemplares similares